Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Live Attenuated Japanese Encephalitis Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
0.5ml Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Live Attenuated Japanese Encephalitis Vaccine include Novartis, Sanofi, Chengdu Institute of Biological Products, Wuhan Institute of Biological Products, Lanzhou Institute of Biological Products, Beijing Temple of Heaven Biological Products, Valneva, Bharat Biotech and Cheng Da Biology, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Epidemic Japanese encephalitis (hereinafter referred to as "JE") is an acute infectious disease of the central nervous system caused by the Japanese encephalitis virus, with inflammation of the brain parenchyma as the main lesion.
This report aims to provide a comprehensive presentation of the global market for Live Attenuated Japanese Encephalitis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Live Attenuated Japanese Encephalitis Vaccine. This report contains market size and forecasts of Live Attenuated Japanese Encephalitis Vaccine in global, including the following market information:
Global Live Attenuated Japanese Encephalitis Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Live Attenuated Japanese Encephalitis Vaccine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Live Attenuated Japanese Encephalitis Vaccine companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Live Attenuated Japanese Encephalitis Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Live Attenuated Japanese Encephalitis Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Live Attenuated Japanese Encephalitis Vaccine Market Segment Percentages, by Type, 2022 (%)
0.5ml
1ml
2.5ml
Global Live Attenuated Japanese Encephalitis Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Live Attenuated Japanese Encephalitis Vaccine Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Global Live Attenuated Japanese Encephalitis Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Live Attenuated Japanese Encephalitis Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Live Attenuated Japanese Encephalitis Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Live Attenuated Japanese Encephalitis Vaccine revenues share in global market, 2022 (%)
Key companies Live Attenuated Japanese Encephalitis Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Live Attenuated Japanese Encephalitis Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Sanofi
Chengdu Institute of Biological Products
Wuhan Institute of Biological Products
Lanzhou Institute of Biological Products
Beijing Temple of Heaven Biological Products
Valneva
Bharat Biotech
Cheng Da Biology
Biocelect Pty Ltd
Glovax Co., Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Live Attenuated Japanese Encephalitis Vaccine, market overview.
Chapter 2: Global Live Attenuated Japanese Encephalitis Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Live Attenuated Japanese Encephalitis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Live Attenuated Japanese Encephalitis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Live Attenuated Japanese Encephalitis Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Live Attenuated Japanese Encephalitis Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Live Attenuated Japanese Encephalitis Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Live Attenuated Japanese Encephalitis Vaccine Overall Market Size
2.1 Global Live Attenuated Japanese Encephalitis Vaccine Market Size: 2022 VS 2029
2.2 Global Live Attenuated Japanese Encephalitis Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Live Attenuated Japanese Encephalitis Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Live Attenuated Japanese Encephalitis Vaccine Players in Global Market
3.2 Top Global Live Attenuated Japanese Encephalitis Vaccine Companies Ranked by Revenue
3.3 Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Companies
3.4 Global Live Attenuated Japanese Encephalitis Vaccine Sales by Companies
3.5 Global Live Attenuated Japanese Encephalitis Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Live Attenuated Japanese Encephalitis Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Live Attenuated Japanese Encephalitis Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Live Attenuated Japanese Encephalitis Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Live Attenuated Japanese Encephalitis Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Live Attenuated Japanese Encephalitis Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Live Attenuated Japanese Encephalitis Vaccine Market Size Markets, 2022 & 2029
4.1.2 0.5ml
4.1.3 1ml
4.1.4 2.5ml
4.2 By Type - Global Live Attenuated Japanese Encephalitis Vaccine Revenue & Forecasts
4.2.1 By Type - Global Live Attenuated Japanese Encephalitis Vaccine Revenue, 2018-2023
4.2.2 By Type - Global Live Attenuated Japanese Encephalitis Vaccine Revenue, 2024-2029
4.2.3 By Type - Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share, 2018-2029
4.3 By Type - Global Live Attenuated Japanese Encephalitis Vaccine Sales & Forecasts
4.3.1 By Type - Global Live Attenuated Japanese Encephalitis Vaccine Sales, 2018-2023
4.3.2 By Type - Global Live Attenuated Japanese Encephalitis Vaccine Sales, 2024-2029
4.3.3 By Type - Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share, 2018-2029
4.4 By Type - Global Live Attenuated Japanese Encephalitis Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Live Attenuated Japanese Encephalitis Vaccine Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Live Attenuated Japanese Encephalitis Vaccine Revenue & Forecasts
5.2.1 By Application - Global Live Attenuated Japanese Encephalitis Vaccine Revenue, 2018-2023
5.2.2 By Application - Global Live Attenuated Japanese Encephalitis Vaccine Revenue, 2024-2029
5.2.3 By Application - Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share, 2018-2029
5.3 By Application - Global Live Attenuated Japanese Encephalitis Vaccine Sales & Forecasts
5.3.1 By Application - Global Live Attenuated Japanese Encephalitis Vaccine Sales, 2018-2023
5.3.2 By Application - Global Live Attenuated Japanese Encephalitis Vaccine Sales, 2024-2029
5.3.3 By Application - Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share, 2018-2029
5.4 By Application - Global Live Attenuated Japanese Encephalitis Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Live Attenuated Japanese Encephalitis Vaccine Market Size, 2022 & 2029
6.2 By Region - Global Live Attenuated Japanese Encephalitis Vaccine Revenue & Forecasts
6.2.1 By Region - Global Live Attenuated Japanese Encephalitis Vaccine Revenue, 2018-2023
6.2.2 By Region - Global Live Attenuated Japanese Encephalitis Vaccine Revenue, 2024-2029
6.2.3 By Region - Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share, 2018-2029
6.3 By Region - Global Live Attenuated Japanese Encephalitis Vaccine Sales & Forecasts
6.3.1 By Region - Global Live Attenuated Japanese Encephalitis Vaccine Sales, 2018-2023
6.3.2 By Region - Global Live Attenuated Japanese Encephalitis Vaccine Sales, 2024-2029
6.3.3 By Region - Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Live Attenuated Japanese Encephalitis Vaccine Revenue, 2018-2029
6.4.2 By Country - North America Live Attenuated Japanese Encephalitis Vaccine Sales, 2018-2029
6.4.3 US Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
6.4.4 Canada Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
6.4.5 Mexico Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Live Attenuated Japanese Encephalitis Vaccine Revenue, 2018-2029
6.5.2 By Country - Europe Live Attenuated Japanese Encephalitis Vaccine Sales, 2018-2029
6.5.3 Germany Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
6.5.4 France Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
6.5.5 U.K. Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
6.5.6 Italy Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
6.5.7 Russia Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
6.5.9 Benelux Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Live Attenuated Japanese Encephalitis Vaccine Revenue, 2018-2029
6.6.2 By Region - Asia Live Attenuated Japanese Encephalitis Vaccine Sales, 2018-2029
6.6.3 China Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
6.6.4 Japan Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
6.6.5 South Korea Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
6.6.7 India Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Live Attenuated Japanese Encephalitis Vaccine Revenue, 2018-2029
6.7.2 By Country - South America Live Attenuated Japanese Encephalitis Vaccine Sales, 2018-2029
6.7.3 Brazil Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
6.7.4 Argentina Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales, 2018-2029
6.8.3 Turkey Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
6.8.4 Israel Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
6.8.6 UAE Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Live Attenuated Japanese Encephalitis Vaccine Major Product Offerings
7.1.4 Novartis Live Attenuated Japanese Encephalitis Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Sanofi
7.2.1 Sanofi Company Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Live Attenuated Japanese Encephalitis Vaccine Major Product Offerings
7.2.4 Sanofi Live Attenuated Japanese Encephalitis Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Sanofi Key News & Latest Developments
7.3 Chengdu Institute of Biological Products
7.3.1 Chengdu Institute of Biological Products Company Summary
7.3.2 Chengdu Institute of Biological Products Business Overview
7.3.3 Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Major Product Offerings
7.3.4 Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Chengdu Institute of Biological Products Key News & Latest Developments
7.4 Wuhan Institute of Biological Products
7.4.1 Wuhan Institute of Biological Products Company Summary
7.4.2 Wuhan Institute of Biological Products Business Overview
7.4.3 Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Major Product Offerings
7.4.4 Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Wuhan Institute of Biological Products Key News & Latest Developments
7.5 Lanzhou Institute of Biological Products
7.5.1 Lanzhou Institute of Biological Products Company Summary
7.5.2 Lanzhou Institute of Biological Products Business Overview
7.5.3 Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Major Product Offerings
7.5.4 Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Lanzhou Institute of Biological Products Key News & Latest Developments
7.6 Beijing Temple of Heaven Biological Products
7.6.1 Beijing Temple of Heaven Biological Products Company Summary
7.6.2 Beijing Temple of Heaven Biological Products Business Overview
7.6.3 Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Major Product Offerings
7.6.4 Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Beijing Temple of Heaven Biological Products Key News & Latest Developments
7.7 Valneva
7.7.1 Valneva Company Summary
7.7.2 Valneva Business Overview
7.7.3 Valneva Live Attenuated Japanese Encephalitis Vaccine Major Product Offerings
7.7.4 Valneva Live Attenuated Japanese Encephalitis Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Valneva Key News & Latest Developments
7.8 Bharat Biotech
7.8.1 Bharat Biotech Company Summary
7.8.2 Bharat Biotech Business Overview
7.8.3 Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Major Product Offerings
7.8.4 Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Bharat Biotech Key News & Latest Developments
7.9 Cheng Da Biology
7.9.1 Cheng Da Biology Company Summary
7.9.2 Cheng Da Biology Business Overview
7.9.3 Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Major Product Offerings
7.9.4 Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 Cheng Da Biology Key News & Latest Developments
7.10 Biocelect Pty Ltd
7.10.1 Biocelect Pty Ltd Company Summary
7.10.2 Biocelect Pty Ltd Business Overview
7.10.3 Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Major Product Offerings
7.10.4 Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 Biocelect Pty Ltd Key News & Latest Developments
7.11 Glovax Co., Ltd.
7.11.1 Glovax Co., Ltd. Company Summary
7.11.2 Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Business Overview
7.11.3 Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Major Product Offerings
7.11.4 Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 Glovax Co., Ltd. Key News & Latest Developments
8 Global Live Attenuated Japanese Encephalitis Vaccine Production Capacity, Analysis
8.1 Global Live Attenuated Japanese Encephalitis Vaccine Production Capacity, 2018-2029
8.2 Live Attenuated Japanese Encephalitis Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Live Attenuated Japanese Encephalitis Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Live Attenuated Japanese Encephalitis Vaccine Supply Chain Analysis
10.1 Live Attenuated Japanese Encephalitis Vaccine Industry Value Chain
10.2 Live Attenuated Japanese Encephalitis Vaccine Upstream Market
10.3 Live Attenuated Japanese Encephalitis Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Live Attenuated Japanese Encephalitis Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
